Roberts, Glore & Co’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
4,391
+140
| +3% | +$43.9K | 0.4% | 63 |
|
|
2025
Q1 | $1.3M | Buy |
4,251
+90
| +2% | +$27.4K | 0.4% | 63 |
|
|
2024
Q4 | $1.38M | Buy |
4,161
+80
| +2% | +$26.6K | 0.41% | 63 |
|
|
2024
Q3 | $1.36M | Sell |
4,081
-25
| -0.6% | -$8.35K | 0.39% | 65 |
|
|
2024
Q2 | $1.69M | Sell |
4,106
-656
| -14% | -$270K | 0.51% | 53 |
|
|
2024
Q1 | $1.92M | Sell |
4,762
-668
| -12% | -$270K | 0.58% | 47 |
|
|
2023
Q4 | $1.66M | Sell |
5,430
-422
| -7% | -$129K | 0.52% | 51 |
|
|
2023
Q3 | $1.42M | Hold |
5,852
| – | – | 0.47% | 58 |
|
|
2023
Q2 | $1.41M | Buy |
5,852
+45
| +0.8% | +$10.8K | 0.45% | 57 |
|
|
2023
Q1 | $1.09M | Sell |
5,807
-85
| -1% | -$16K | 0.37% | 70 |
|
|
2022
Q4 | $1.25M | Sell |
5,892
-441
| -7% | -$93.7K | 0.43% | 58 |
|
|
2022
Q3 | $995K | Sell |
6,333
-40
| -0.6% | -$6.29K | 0.36% | 69 |
|
|
2022
Q2 | $954K | Buy |
6,373
+4,103
| +181% | +$614K | 0.32% | 76 |
|
|
2022
Q1 | $371K | Buy |
+2,270
| New | +$371K | 0.11% | 148 |
|